000
| 01967nam 2200325za 4500 |
---|
001 | 9.825318 |
---|
003 | CaOODSP |
---|
005 | 20221107144328 |
---|
007 | cr ||||||||||| |
---|
008 | 161003s2016 onc ob f000 0 eng d |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH113-9/2016-26E-PDF |
---|
245 | 00|aBacillus mycoides isolate J |h[electronic resource]. |
---|
260 | |aOttawa : |bHealth Canada, |cc2016. |
---|
300 | |a44 p. |
---|
490 | 1 |aProposed registration decision, |x1925-0886 ; |vPRD2016-26 |
---|
500 | |aIssued also in French under title: Isolat J de Bacillus mycoides. |
---|
500 | |a"28 September 2016.” |
---|
504 | |aIncludes references. |
---|
520 | |a"Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of BmJ TGAI and BmJ WG, containing the technical grade active ingredient Bacillus mycoides isolate J, for the suppression or partial suppression of certain fungal diseases on food crops. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of BmJ TGAI and BmJ WG"--Overview. |
---|
530 | |aIssued also in printed form. |
---|
692 | 07|2gccst|aPesticides |
---|
692 | 07|2gccst|aCertification |
---|
692 | 07|2gccst|aToxicology |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
710 | 1 |aCanada. |bPest Management Regulatory Agency. |
---|
775 | 08|tIsolat J de Bacillus mycoides |w(CaOODSP)9.825321 |
---|
830 | #0|aProposed registration decision,|x1925-0886 ; |vPRD2016-26|w(CaOODSP)9.504464 |
---|
856 | 40|qPDF|s361 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H113-9-2016-26-eng.pdf |
---|